Germany
· Delayed Price · Currency is EUR SkinBioTherapeutics Statistics
Total Valuation
FRA:5KW has a market cap or net worth of EUR 44.83 million. The enterprise value is 40.49 million.
| Market Cap | 44.83M |
| Enterprise Value | 40.49M |
Important Dates
The last earnings date was Tuesday, December 2, 2025.
| Earnings Date | Dec 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 258.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +20.57% |
| Shares Change (QoQ) | +13.96% |
| Owned by Insiders (%) | 19.89% |
| Owned by Institutions (%) | 67.98% |
| Float | 165.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.28 |
| PB Ratio | 4.08 |
| P/TBV Ratio | 7.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -49.85 |
| EV / Sales | 7.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -27.96 |
Financial Position
The company has a current ratio of 4.84, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.84 |
| Quick Ratio | 4.29 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.80 |
| Interest Coverage | -12.21 |
Financial Efficiency
Return on equity (ROE) is -11.24% and return on invested capital (ROIC) is -9.89%.
| Return on Equity (ROE) | -11.24% |
| Return on Assets (ROA) | -8.10% |
| Return on Invested Capital (ROIC) | -9.89% |
| Return on Capital Employed (ROCE) | -10.54% |
| Revenue Per Employee | 360,724 |
| Profits Per Employee | -54,150 |
| Employee Count | 15 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.80 |
Taxes
| Income Tax | -22,006 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.73% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.73% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 40.16 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:5KW had revenue of EUR 5.41 million and -812,247 in losses. Loss per share was -0.00.
| Revenue | 5.41M |
| Gross Profit | 3.34M |
| Operating Income | -1.31M |
| Pretax Income | -834,253 |
| Net Income | -812,247 |
| EBITDA | -955,148 |
| EBIT | -1.31M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 5.58 million in cash and 1.16 million in debt, giving a net cash position of 4.42 million.
| Cash & Cash Equivalents | 5.58M |
| Total Debt | 1.16M |
| Net Cash | 4.42M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 10.99M |
| Book Value Per Share | 0.05 |
| Working Capital | 6.58M |
Cash Flow
In the last 12 months, operating cash flow was -1.44 million and capital expenditures -7,350, giving a free cash flow of -1.45 million.
| Operating Cash Flow | -1.44M |
| Capital Expenditures | -7,350 |
| Free Cash Flow | -1.45M |
| FCF Per Share | n/a |
Margins
Gross margin is 61.65%, with operating and profit margins of -24.22% and -15.01%.
| Gross Margin | 61.65% |
| Operating Margin | -24.22% |
| Pretax Margin | -15.42% |
| Profit Margin | -15.01% |
| EBITDA Margin | -17.65% |
| EBIT Margin | -24.22% |
| FCF Margin | n/a |
Dividends & Yields
FRA:5KW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.57% |
| Shareholder Yield | -20.57% |
| Earnings Yield | -1.81% |
| FCF Yield | -3.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |